Navigation Links
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
Date:11/6/2009

testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with an $18 million IPCAVD grant awarded in late 2007.

Safe Harbor Statement

All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.

More information is available on the Company's website at www.geovax.com.

SOURCE GeoVax Labs, Inc.


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
2. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
3. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
4. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
5. GeoVax Reports Progress on Its AIDS Vaccine Technology
6. GeoVax Secures $10 Million Financing Commitment
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
10. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
11. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- It is no secret ... third being overweight or obese gyms and supplement companies are ... the condition is primarily related to dietary issues and a ... the result of a glandular problem or even a vitamin ... common vitamin deficiency is a lack of vitamin b12 ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11
... N.J., May 03, 2007 /PRNewswire-FirstCall/ --,Alpharma ... pharmaceutical company,through its Pharmaceuticals Division, this ... study of its investigational,abuse-deterrent, extended-release opioid ... the American Pain Society in Washington, ...
... /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced today that ... International Conference on Antiviral,Research being held in ... virus (HCV) polymerase inhibitor,discovered by Genelabs. , ... D. Roberts,Ph.D., Director of Medicinal Chemistry at ...
Cached Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
(Date:5/20/2013)... People are so busy these days, running from ... the roof and are contributing to a number of health ... the difference between life and death. Speakers at the upcoming ... will share valuable, practical tools people can use to boost ... them for social good. , Organised by V Star ...
(Date:5/20/2013)... The Environmental Design Research ... of continuing education credit opportunities for design professionals, ... Architects Continuing Education System (AIA/CES), the Landscape Architecture ... Design Continuing Education Council (IDCEC). EDRA44Providence ... at the Omni Providence Hotel in Providence, Rhode ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Osborn’s ... successor to Anne G. Osborn’s 1993 award winning book ... of the all-time bestselling neuroradiology texts. , In ... special touch to make complex topics visually appealing and ... of brain imaging together with spectacular pathology examples, relevant ...
(Date:5/20/2013)... Huntington,s disease (HD) is currently incurable, the HD ... development may slow or minimize disease progression. ... identification of reliable and sensitive biomarkers to track ... eventually be used as outcome measures in clinical ... changes during the time prior to diagnosis and ...
(Date:5/20/2013)... 20, 2013 National law firm Parker Waichman ... Law Firm P.A., both based in Little Rock, Arkansas – ... proposed $7.25 billion settlement of a price-fixing case against Visa ... was filed Wednesday, May 15, 2013, in the U.S. District ... lawsuit against Visa and MasterCard (Case No. 1:05-md-1720) is titled ...
Breaking Medicine News(10 mins):Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:Osborn’s Brain from Amirsys Publishing Receives Doody’s Top Honors 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3
... sudden cardiac arrest , , MONDAY, Jan. 5 (HealthDay News) -- ... like that. , "I was swimming in a pool at ... was 23 years old and in excellent health, or so ... to a stop face down." , Jim Stoltz,s heart stopped ...
... 5 When Lamont Christian,returned from war, he often felt ... a homeless shelter, a sign that time had not,healed his ... the VA Ann Arbor Healthcare System for help, and there, ... depression, post-,traumatic stress disorder and anger management problems. Now, he ...
... A leader in quality laminate,casework is aiming to become the ... is designed to offer customers guaranteed quicker,delivery. , ... according to Case Systems,President and COO Rick Vander Weele. , ... Vander Weele says. "Regardless of,an order,s size, standard shipping from ...
... Jan. 5 Based on its recent analysis,of ... Toshiba,America Medical Systems with the 2008 North American ... has launched a variety of,cardiovascular imaging devices, including ... line. This product has taken,echocardiography a step ahead ...
... IRVING, Texas, Jan. 5 RBC Life Sciences ... has elected current president, John W. Price, to CEO ... is currently CEO, will remain as chairman of the ... RBC Life Sciences, a global provider of proprietary nutritional ...
... Ensign Group, Inc. (Nasdaq: ENSG ), ... Center, a 150-bed skilled nursing facility in Lufkin, ... The facility has been renamed Southland Rehabilitation & ... a strategic acquisition, and adds to our growing ...
Cached Medicine News:Health News:When the Heart Stops Beating 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 3Health News:CaseQ Quick Ship Casework Program Announced Today 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 4Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: